Anglais
French
Gerges RIZKALLAH
Faculté de pharmacie – Chargé de cours
+961 (1) 421 000 gerges.rizkallah1@usj.edu.lb
<p class="MsoNormal" style="text-align:justify"><b><i><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Lieuet Date de naissance </span></i></b><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">: Beyrouth, le 14 Juillet1985</span></p>
Education
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| PhD in biology - speciality virology | Université de Lyon1 | France | 2017 |
| Master | Saint Joseph University of Beyrouth | Lebanon | 2013 |
| Clinical and Hospital Pharmacy | Saint Joseph University of Beyrouth | Lebanon | 2011 |
| Doctor of pharmacy | Saint Joseph University of Beyrouth | Lebanon | 2009 |
Teaching at USJ
University teaching outside USJ
| University teaching outside USJ | Pays | Institution | Start date | End date |
|---|---|---|---|---|
| Lebanon | Université la Sagesse (ULS) | 09/01/2018 |
Professional experience outside USJ
Areas of expertise
Research themes
<div>Virologie</div><div>Bactériologie</div><div>Culture cellulaire</div><div>Cytométrie de flux<br></div>
Publications and communications
<p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-list:l0 level1 lfo2;mso-layout-grid-align:none;text-autospace:none"><span style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Septembre 2019 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR"><u>Rizkallah Gerges</u>, Renaud Mahieux,Hélène Dutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif"">‘</span><span style="font-size:11.0pt;font-family:"Garamond","serif";mso-bidi-font-family:FuturaBT-Medium">Clinical Approaches of HIV-1/HTLV-1 Co-infection Still Keeptheir Mysteries</span><span style="font-size:11.0pt;font-family:"Garamond","serif"">?’’Journal of infectiology, August 30, 2019</span><span style="font-size:11.0pt;font-family:"Garamond","serif";mso-bidi-font-family:FuturaBT-Medium"></span></p><p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-pagination:none;mso-list:l1 level1 lfo1;tab-stops:list .25in;mso-layout-grid-align:none;text-autospace:none"><span style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Décembre 2018 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR"> <u>Rizkallah Gerges</u> and HélèneDutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif"">‘’Acontinuing journey for HTLV-1 antiviral development?’’ <i>EC microbiology, </i>December28, 2018</span></p><p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-pagination:none;mso-list:l1 level1 lfo1;tab-stops:list .25in;mso-layout-grid-align:none;text-autospace:none"><span style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-font-kerning:12.0pt;mso-ansi-language:FR;mso-bidi-font-weight:bold">Octobre2017 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-font-kerning:12.0pt;mso-ansi-language:FR;mso-bidi-font-weight:bold"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Rizkallah Gerges</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">, Chloé Journo, RenaudMahieux, and Hélène Dutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif"">“How Does Susceptibility to HTLV-1 Infection Varies withthe Maturation State of Dendritic Cells?” <i>Future Virology</i>, October 11,2017. doi:10.2217/fvl-2017-0075.</span></p><p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-list:l1 level1 lfo1;tab-stops:list .25in"><span style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings;mso-font-kerning:12.0pt;mso-bidi-font-weight:bold"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-font-kerning:12.0pt;mso-ansi-language:FR;mso-bidi-font-weight:bold">Octobre 2017 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-font-kerning:12.0pt;mso-ansi-language:FR;mso-bidi-font-weight:bold"> Teruel, Élodie, <u>Gerges Rizkallah</u>, Chloé Journo, and Hélène Dutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif";mso-font-kerning:12.0pt;mso-bidi-font-weight:bold">“[The actin cytoskeleton goes retroviral].” MedecineSciences: M/S 33, no. 10 (October 2017): 839–42.doi:10.1051/medsci/20173310009.</span></p><p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-list:l1 level1 lfo1;tab-stops:list .25in"><span style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR;mso-bidi-font-weight:bold">Avril 2017 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR;mso-bidi-font-weight:bold"> </span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Rizkallah,Gergès</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">, Sandrine Alais, Nicolas Futsch, Yuetsu Tanaka, ChloéJourno, Renaud Mahieux, and Hélène Dutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif"">“Dendritic Cell Maturation, but Not TypeI Interferon Exposure, Restricts Infection by HTLV-1, and Viral Transmission toT-Cells.” <i>PLoS Pathogens</i> 13, no. 4 (April 2017): e1006353.doi:10.1371/journal.ppat.1006353.</span></p><p class="MsoNormal" style="margin-left:.25in;text-align:justify;text-indent:-.25in;mso-list:l1 level1 lfo1;tab-stops:list .25in"><span lang="FR" style="font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings;mso-ansi-language:FR"><span style="mso-list:Ignore">§<span style="font:7.0pt "Times New Roman""> </span></span></span><span dir="LTR"></span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR">Juillet 2015 :</span></u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR"> <u>Gerges</u>, Renaud Mahieux, and Hélène Dutartre. </span><span style="font-size:11.0pt;font-family:"Garamond","serif"">“[Intercellulartransmission of HTLV-1: not all mechanisms have been revealed].” <i>MedecineSciences: M/S</i> 31, no. 6–7 (July 2015): 629–37.doi:10.1051/medsci/20153106016.</span><u><span lang="FR" style="font-size:11.0pt;font-family:"Garamond","serif";mso-ansi-language:FR"></span></u></p>